By Professor Deborah Cromer

Journal articles

Pinkevych M; Docken SS; Wu Y; Schlub T; Harper JL; Viox EG; Samer S; Kulpa D; Betts MR; Keele BF; Paiardini M; Bar KJ; Cromer D; Davenport MP, 2026, 'The rebound-initiating viral reservoir (RIVR) in SIV/SHIV infection is dominated by plasma virus sequences present at the time of ART initiation.', Journal of Virology, pp. e0036626, http://dx.doi.org/10.1128/jvi.00366-26

Reynaldi A; Lee WS; Selva KJ; Audsley J; Trieu MC; Chung AW; Cromer D; Tan HX; Wheatley AK; Juno JA; Khoury DS; Davenport MP; Kent SJ, 2026, 'Immune responses associated with protection from SARS-CoV-2 infection', Vaccine, 81, http://dx.doi.org/10.1016/j.vaccine.2026.128579

Arlinda D; Yunihastuti E; Indrati AR; Merati TP; Papot E; Cromer D; Diana A; Naysilla AM; Dewantara RD; Susanto NH; Lukman N; Pranata WA; Kosasih H; Lokida D; Karyana M; Hartono TS; Kosa GR; Theresia D; Savitri D; Nugroho DK; Eppy E; Utama MS; Jamil KF; Toruan IL; Samosir NE; Katu S; Farhanah N; Wahyunie S; Rusli M; Swastika WA; Wullur WAI; Subronto YW; Jason Liang C; Ridzon R; Chen RY; Neal AT; Wisaksana R; Alam A; Nurmawati S; Chairunnisa NH; Dwi OK; Djauhari H; Sunarko S; Merati TP; Somia KA; Utama MS; Dian Sukmawati NMD; Gayatri AAY; Wati KDK; Lestari AAW; Fatmawati NND; Ariastuti NLP; Satriawati NP; Lestari NK; Jumanti NWD; Setiani NN; Purinawa G; Artini DP; Sutarni NNS; Kurniati N; Kumalawati J; Harinda F; Putri TK; Madyaningati ; Chasanah WA; Amin DM; Rusli A; Mardiyah NF; Reskianingsih A; Hindawati E; Fitriani ; Pelupessy NM; Munawir ; Nurulita A; Ayu DR; Bakri RA; Hardiansyah MF; Sriyanti D; Kartini ; Nurdin N; Tessyoja A; Sofro MAU; Arkhaesi N; Rahayu M; Adlina R; Erni ; Wahyuningtias T; Kusumo BS; Ngatno ; Hadi U; Puspitasari D; Fitriah M; Arfijanto MV; Bramantono ; Rusli M; Adeline ME, 2026, 'Annual trends and risk factors of late presentation of HIV at 19 referral hospitals in Indonesia: findings from the INA-PROACTIVE cohort', Lancet Regional Health Southeast Asia, 46, http://dx.doi.org/10.1016/j.lansea.2026.100742

Docken SS; Macairan A; Schlub TE; Fennessey CM; Varco-Merth B; Picker LJ; Okoye AA; Immonen TT; Cromer D; Keele BF; Davenport MP, 2026, 'Dissecting the steps in early simian immunodeficiency virus dissemination following mucosal and intravenous infection of rhesus macaques', Journal of Virology, 100, http://dx.doi.org/10.1128/jvi.01485-25

Trieu MC; Reynaldi A; Lee WS; Tan HX; Kelly A; Esterbauer R; Cox RJ; Audsley J; Sasadeusz J; Khoury DS; Davenport MP; Cromer D; Wheatley AK; Kent SJ; Juno JA, 2025, 'Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens', Npj Vaccines, 10, pp. 74, http://dx.doi.org/10.1038/s41541-025-01129-6

Claiborne DT; Detwiler Z; Docken SS; Borland TD; Cromer D; Simkhovich A; Ophinni Y; Okawa K; Bateson T; Chen T; Hudson W; Trifonova R; Davenport MP; Ho TW; Boutwell CL; Allen TM, 2025, 'High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection', Nature Communications, 16, pp. 446, http://dx.doi.org/10.1038/s41467-025-55873-3

Berry MT; MacIntyre CR; Cromer D; Hacker A; Davenport MP; Khoury DS, 2025, 'Optimal deployment of limited vaccine supplies to control mpox outbreaks', Npj Vaccines, 10, http://dx.doi.org/10.1038/s41541-025-01289-5

Le TP; Conway E; Akpan E; Abell IR; Abraham P; Baker CM; Campbell PT; Cromer D; Lydeamore MJ; McDonough Y; Mueller I; Ryan G; Walker C; Wang Y; Carvalho N; McVernon J, 2025, 'Health impact and cost-effectiveness of COVID-19 booster vaccination strategies in the early post-Omicron era: a dynamic modelling study', BMJ Global Health, 10, http://dx.doi.org/10.1136/bmjgh-2024-016096

Khoury DS; Cromer D; Bailey B; Khan SR; Burnett DL; Kent SJ; Rudd BD; Marchant A; Turner T; Davenport MP, 2025, 'Towards evidence-based immunology', Nature Immunology, 26, pp. 980 - 982, http://dx.doi.org/10.1038/s41590-025-02180-0

Dhenni R; Hoppé AC; Reynaldi A; Kyaw W; Handoko NT; Grootveld AK; Keith YH; Bhattacharyya ND; Ahel HI; Telfser AJ; McCorkindale AN; Yazar S; Bui CHT; Smith JT; Khoo WH; Boyd M; Obeid S; Milner B; Starr M; Brilot F; Milogiannakis V; Akerman A; Aggarwal A; Davenport MP; Deenick EK; Chaffer CL; Croucher PI; Brink R; Goldstein LD; Cromer D; Turville SG; Kelleher AD; Venturi V; Munier CML; Phan TG, 2025, 'Macrophages direct location-dependent recall of B cell memory to vaccination', Cell, 188, pp. 3477 - 3496.e22, http://dx.doi.org/10.1016/j.cell.2025.04.005

Hao T; Ryan GE; Lydeamore MJ; Cromer D; Wood JG; McVernon J; McCaw JM; Shearer FM; Golding N, 2025, 'Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19', Vaccine, 55, pp. 126987, http://dx.doi.org/10.1016/j.vaccine.2025.126987

Lee WS; Selva KJ; Audsley J; Kent HE; Reynaldi A; Schlub TE; Cromer D; Khoury DS; Peck H; Aban M; Vu MN; Zheng MZM; Chung AW; Koutsakos M; Tan HX; Wheatley AK; Juno JA; Rockman S; Davenport MP; Barr I; Kent SJ, 2025, 'Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines', Jci Insight, 10, pp. e187075, http://dx.doi.org/10.1172/jci.insight.187075

Hastak P; Cromer D; Malycha J; Andersen CR; Raith E; Davenport MP; Plummer M; Sasson SC, 2024, 'Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia', Scientific Reports, 14, pp. 11102, http://dx.doi.org/10.1038/s41598-024-61729-5

Cromer D; Reynaldi A; Mitchell A; Schlub TE; Juno JA; Wheatley AK; Kent SJ; Khoury DS; Davenport MP, 2024, 'Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates', Nature Communications, 15, pp. 8395, http://dx.doi.org/10.1038/s41467-024-52194-9

Revoltar M; van der Linde R; Cromer D; Gatt PN; Smith S; Fernandez MA; Vaughan L; Blyth E; Curnow J; Tegg E; Brown DA; Sasson SC, 2024, 'Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemia', Pathology, 56, pp. 882 - 888, http://dx.doi.org/10.1016/j.pathol.2024.04.009

Elias KM; Khan SR; Stadler E; Schlub TE; Cromer D; Polizzotto MN; Kent SJ; Turner T; Davenport MP; Khoury DS, 2024, 'Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis', Lancet Microbe, 5, pp. e459 - e467, http://dx.doi.org/10.1016/S2666-5247(23)00398-1

Stadler E; Cromer D; Ogunlade S; Ongoiba A; Doumbo S; Kayentao K; Traore B; Crompton PD; Portugal S; Davenport MP; Khoury DS, 2023, 'Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data', Malaria Journal, 22, http://dx.doi.org/10.1186/s12936-023-04461-1

Stadler E; Burgess MT; Schlub TE; Khan SR; Chai KL; McQuilten ZK; Wood EM; Polizzotto MN; Kent SJ; Cromer D; Davenport MP; Khoury DS, 2023, 'Monoclonal antibody levels and protection from COVID-19', Nature Communications, 14, pp. 4545, http://dx.doi.org/10.1038/s41467-023-40204-1

Cromer D; Steain M; Reynaldi A; Schlub TE; Khan SR; Sasson SC; Kent SJ; Khoury DS; Davenport MP, 2023, 'Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis', Nature Communications, 14, pp. 1633, http://dx.doi.org/10.1038/s41467-023-37176-7

Stadler E; Chai KL; Schlub TE; Cromer D; Khan SR; Polizzotto MN; Kent SJ; Beecher C; White H; Turner T; Skoetz N; Estcourt L; McQuilten ZK; Wood EM; Khoury DS; Davenport MP, 2023, 'Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis', Lancet Microbe, 4, pp. e883 - e892, http://dx.doi.org/10.1016/S2666-5247(23)00194-5

Docken SS; McCormick K; Pampena MB; Samer S; Lindemuth E; Pinkevych M; Viox EG; Wu Y; Schlub TE; Cromer D; Keele BF; Paiardini M; Betts MR; Bar KJ; Davenport MP, 2023, 'Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency', Plos Pathogens, 19, pp. e1011755, http://dx.doi.org/10.1371/journal.ppat.1011755

Zachreson C; Tobin R; Szanyi J; Walker C; Cromer D; Shearer FM; Conway E; Ryan G; Cheng A; McCaw JM; Geard N, 2023, 'Individual variation in vaccine immune response can produce bimodal distributions of protection', Vaccine, 41, pp. 6630 - 6636, http://dx.doi.org/10.1016/j.vaccine.2023.09.025

Lee WS; Tan HX; Reynaldi A; Esterbauer R; Koutsakos M; Nguyen J; Amarasena T; Kent HE; Aggarwal A; Turville SG; Taiaroa G; Kinsella P; Liew KC; Tran T; Williamson DA; Cromer D; Davenport MP; Kent SJ; Juno JA; Khoury DS; Wheatley AK, 2023, 'Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection', Science Advances, 9, pp. eadg5301, http://dx.doi.org/10.1126/sciadv.adg5301

Khoury DS; Docken SS; Subbarao K; Kent SJ; Davenport MP; Cromer D, 2023, 'Predicting the efficacy of variant-modified COVID-19 vaccine boosters', Nature Medicine, 29, pp. 574 - 578, http://dx.doi.org/10.1038/s41591-023-02228-4

Khoury DS; Schlub TE; Cromer D; Steain M; Fong Y; Gilbert PB; Subbarao K; Triccas JA; Kent SJ; Davenport MP, 2023, 'Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection', Emerging Infectious Diseases, 29, pp. 381 - 388, http://dx.doi.org/10.3201/eid2902.221422

Selva KJ; Ramanathan P; Haycroft ER; Reynaldi A; Cromer D; Tan CW; Wang LF; Wines BD; Hogarth PM; Downie LE; Davis SK; Purcell RA; Kent HE; Juno JA; Wheatley AK; Davenport MP; Kent SJ; Chung AW, 2023, 'Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections', Jci Insight, 8, pp. e172470, http://dx.doi.org/10.1172/jci.insight.172470

Stadler E; Cromer D; Mehra S; Adekunle AI; Flegg JA; Anstey NM; Watson JA; Chu CS; Mueller I; Robinson LJ; Schlub TE; Davenport MP; Khoury DS, 2022, 'Population heterogeneity in Plasmodium vivax relapse risk', PLoS Neglected Tropical Diseases, 16, http://dx.doi.org/10.1371/journal.pntd.0010990

SheelaNair A; Romanczuk AS; Aogo RA; Haldar RN; Lansink LIM; Cromer D; Salinas YG; Guy RK; McCarthy JS; Davenport MP; Haque A; Khoury DS, 2022, 'Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice', Malaria Journal, 21, pp. 49, http://dx.doi.org/10.1186/s12936-022-04075-z

Lau JSY; Cromer D; Pinkevych M; Lewin SR; Rasmussen TA; McMahon JH; Davenport MP, 2022, 'Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design', Journal of Infectious Diseases, 226, pp. 236 - 245, http://dx.doi.org/10.1093/infdis/jiac032

Koutsakos M; Lee WS; Reynaldi A; Tan HX; Gare G; Kinsella P; Liew KC; Taiaroa G; Williamson DA; Kent HE; Stadler E; Cromer D; Khoury DS; Wheatley AK; Juno JA; Davenport MP; Kent SJ, 2022, 'The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants', Immunity, 55, pp. 1316 - 1326.e4, http://dx.doi.org/10.1016/j.immuni.2022.05.018

Kent SJ; Khoury DS; Reynaldi A; Juno JA; Wheatley AK; Stadler E; John Wherry E; Triccas J; Sasson SC; Cromer D; Davenport MP, 2022, 'Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?', Nature Reviews Immunology, 22, pp. 387 - 397, http://dx.doi.org/10.1038/s41577-022-00716-1

Aggarwal A; Stella AO; Walker G; Akerman A; Esneau C; Milogiannakis V; Burnett DL; McAllery S; Silva MR; Lu Y; Foster CSP; Brilot F; Pillay A; Van Hal S; Mathivanan V; Fichter C; Kindinger A; Hoppe AC; Munier ML; Amatayakul-Chantler S; Roth N; Coppola G; Symonds GP; Schofield P; Jackson J; Lenthall H; Henry JY; Mazigi O; Jäck HM; Davenport MP; Darley DR; Matthews GV; Khoury DS; Cromer D; Goodnow CC; Christ D; Robosa R; Starck DJ; Bartlett NW; Rawlinson WD; Kelleher AD; Turville SG; Ruiz Silva M, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7

Cele S; Jackson L; Khoury DS; Khan K; Moyo-Gwete T; Tegally H; San JE; Cromer D; Scheepers C; Amoako DG; Karim F; Bernstein M; Lustig G; Archary D; Smith M; Ganga Y; Jule Z; Reedoy K; Hwa SH; Giandhari J; Blackburn JM; Gosnell BI; Abdool Karim SS; Hanekom W; Davies MA; Hsiao M; Martin D; Mlisana K; Wibmer CK; Williamson C; York D; Harrichandparsad R; Herbst K; Jeena P; Khoza T; Kløverpris H; Leslie A; Madansein R; Magula N; Manickchund N; Marakalala M; Mazibuko M; Moshabela M; Mthabela N; Naidoo K; Ndhlovu Z; Ndung’u T; Ngcobo N; Nyamande K; Patel V; Smit T; Steyn A; Wong E; von Gottberg A; Bhiman JN; Lessells RJ; Moosa MYS; Davenport MP; de Oliveira T; Moore PL; Sigal A, 2022, 'Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization', Nature, 602, pp. 654 - 656, http://dx.doi.org/10.1038/s41586-021-04387-1

Cromer D; Steain M; Reynaldi A; Schlub TE; Wheatley AK; Juno JA; Kent SJ; Triccas JA; Khoury DS; Davenport MP, 2022, 'Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis', Lancet Microbe, 3, pp. e52 - e61, http://dx.doi.org/10.1016/S2666-5247(21)00267-6

Cromer D; Reynaldi A; Steain M; Triccas JA; Davenport MP; Khoury DS, 2022, 'Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial', Clinical Infectious Diseases, 75, pp. e878 - e879, http://dx.doi.org/10.1093/cid/ciac075

Wheatley AK; Juno JA; Wang JJ; Selva KJ; Reynaldi A; Tan HX; Lee WS; Wragg KM; Kelly HG; Esterbauer R; Davis SK; Kent HE; Mordant FL; Schlub TE; Gordon DL; Khoury DS; Subbarao K; Cromer D; Gordon TP; Chung AW; Davenport MP; Kent SJ, 2021, 'Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19', Nature Communications, 12, pp. 1162, http://dx.doi.org/10.1038/s41467-021-21444-5

Wheatley AK; Pymm P; Esterbauer R; Dietrich MH; Lee WS; Drew D; Kelly HG; Chan LJ; Mordant FL; Black KA; Adair A; Tan HX; Juno JA; Wragg KM; Amarasena T; Lopez E; Selva KJ; Haycroft ER; Cooney JP; Venugopal H; Tan LL; O Neill MT; Allison CC; Cromer D; Davenport MP; Bowen RA; Chung AW; Pellegrini M; Liddament MT; Glukhova A; Subbarao K; Kent SJ; Tham WH, 2021, 'Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain', Cell Reports, 37, pp. 109822, http://dx.doi.org/10.1016/j.celrep.2021.109822

Khoury DS; Cromer D; Reynaldi A; Schlub TE; Wheatley AK; Juno JA; Subbarao K; Kent SJ; Triccas JA; Davenport MP, 2021, 'Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection', Nature Medicine, 27, pp. 1205 - 1211, http://dx.doi.org/10.1038/s41591-021-01377-8

Lee WS; Selva KJ; Davis SK; Wines BD; Reynaldi A; Esterbauer R; Kelly HG; Haycroft ER; Tan HX; Juno JA; Wheatley AK; Hogarth PM; Cromer D; Davenport MP; Chung AW; Kent SJ, 2021, 'Decay of Fc-dependent antibody functions after mild to moderate COVID-19', Cell Reports Medicine, 2, pp. 100296, http://dx.doi.org/10.1016/j.xcrm.2021.100296

Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP, 2021, 'Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection', Nature Reviews Immunology, 21, pp. 395 - 404, http://dx.doi.org/10.1038/s41577-021-00550-x

Pymm P; Adair A; Chan LJ; Cooney JP; Mordant FL; Allison CC; Lopez E; Haycroft ER; O'Neill MT; Tan LL; Dietrich MH; Drew D; Doerflinger M; Dengler MA; Scott NE; Wheatley AK; Gherardin NA; Venugopal H; Cromer D; Davenport MP; Pickering R; Godfrey DI; Purcell DFJ; Kent SJ; Chung AW; Subbarao K; Pellegrini M; Glukhova A; Tham WH, 2021, 'Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice', Proceedings of the National Academy of Sciences of the United States of America, 118, pp. e2101918118, http://dx.doi.org/10.1073/pnas.2101918118

Khoury DS; Wheatley AK; Ramuta MD; Reynaldi A; Cromer D; Subbarao K; O’Connor DH; Kent SJ; Davenport MP, 2020, 'Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models', Nature Reviews Immunology, 20, pp. 727 - 738, http://dx.doi.org/10.1038/s41577-020-00471-1

Alahmadi A; Belet S; Black A; Cromer D; Flegg JA; House T; Jayasundara P; Keith JM; McCaw JM; Moss R; Ross JV; Shearer FM; Tun STT; Walker CR; White L; Whyte JM; Yan AWC; Zarebski AE, 2020, 'Influencing public health policy with data-informed mathematical models of infectious diseases: Recent developments and new challenges', Epidemics, 32, pp. 100393, http://dx.doi.org/10.1016/j.epidem.2020.100393

Wu Y; Pinkevych M; Xu Z; Keele BF; Davenport MP; Cromer D, 2020, 'Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption', Proceedings of the Royal Society B Biological Sciences, 287, pp. 20200354, http://dx.doi.org/10.1098/rspb.2020.0354

Price DJ; Shearer FM; Meehan MT; McBryde E; Moss R; Golding N; Conway EJ; Dawson P; Cromer D; Wood J; Abbott S; McVernon J; McCaw JM, 2020, 'Early analysis of the australian covid-19 epidemic', Elife, 9, pp. 1 - 14, http://dx.doi.org/10.7554/ELIFE.58785

Khoury DS; Zaloumis SG; Grigg MJ; Haque A; Davenport MP; Cromer D; Rebelo M; Cao P; McCaw JM; Simpson JA; Flegg JA; Wilson DW; Anstey NM; McCarthy JS, 2020, 'Malaria Parasite Clearance: What Are We Really Measuring?', Trends in Parasitology, 36, pp. 413 - 426, http://dx.doi.org/10.1016/j.pt.2020.02.005

Pinkevych M; Fennessey CM; Cromer D; Reid C; Trubey CM; Lifson JD; Keele BF; Davenport MP, 2019, 'Predictors of SIV recrudescence following antiretroviral treatment interruption', Elife, 8, pp. e49022, http://dx.doi.org/10.7554/eLife.49022

Khoury DS; Cromer D; Möhrle JJ; McCarthy JS; Davenport MP, 2019, 'Corrigendum: Defining the effectiveness of antimalarial chemotherapy: Investigation of the lag in parasite clearance following drug administration (Journal of Infectious Diseases (2016) 214 (753-761) DOI: 10.1093/infdis/jiw234)', Journal of Infectious Diseases, 219, pp. 1852 - 1853, http://dx.doi.org/10.1093/infdis/jiy729

Akter J; Khoury DS; Aogo R; Lansink LIM; SheelaNair A; Thomas BS; Laohamonthonkul P; Pernold CPS; Dixon MWA; Soon MSF; Fogg LG; Engel JA; Elliott T; Sebina I; James KR; Cromer D; Davenport MP; Haque A, 2019, 'Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells', Plos Pathogens, 15, pp. e1007599, http://dx.doi.org/10.1371/journal.ppat.1007599

Davenport MP; Khoury DS; Cromer D; Lewin SR; Kelleher AD; Kent SJ, 2019, 'Functional cure of HIV: the scale of the challenge', Nature Reviews Immunology, 19, pp. 45 - 54, http://dx.doi.org/10.1038/s41577-018-0085-4

Back to profile page